Showing 7041-7050 of 9095 results for "".
- ICONIC-TOTAL: Icotrokinra Shows Skin Clearance in Difficult-to-Treat PsO at 1 Yearhttps://practicaldermatology.com/news/iconic-total-icotrokinra-shows-skin-clearance-in-difficult-to-treat-pso-at-1-year/2484061/Icotrokinra, a novel oral IL-23 inhibitor, was associated with imporvements in plaque psoriasis in difficult-to-treat areas of the body, according to new data presented at 2025 Fall Clinical Dermatology Conference in Las Vegas.
- IL-17A Inhibitors Linked with Scalp and Gut Microbiota Improvement in Psoriasis Patientshttps://practicaldermatology.com/news/il-17a-inhibitors-linked-with-scalp-and-gut-microbiota-improvement-in-psoriasis-patients/2484034/Treatment with IL-17A inhibitors may help rebalance disrupted scalp and gut microbiota in patients with moderate-to-severe psoriasis vulgaris, according to a new study. Researchers collected scalp and fecal samples from 15 adu
- Study: Low-Calorie Diet May Increase PsA Riskhttps://practicaldermatology.com/news/study-low-calorie-diet-may-increase-psa-risk/2483973/A low-calorie diet may increase the risk of developing psoriatic arthritis, according to findings from a Mendelian randomization (MR) study published in Clinical, Cosmetic and Investigational Dermatology.
- Risk-Guided Screening Enhances Early Skin Cancer ID in Transplant Cohorthttps://practicaldermatology.com/news/risk-guided-screening-enhances-early-skin-cancer-id-in-transplant-cohort/2483972/A risk-based skin cancer surveillance strategy was associated with improved early detection rates among solid organ transplant (SOT) recipients, according to findings from a recent retrospective cohort analysis of the implementation of the KP-SUNTRAC program across K
- Study Links Structural and Immune Risk Factors to Skin Conditions in PWHhttps://practicaldermatology.com/news/study-links-structural-and-immune-risk-factors-to-skin-conditions-in-pwh/2483949/Nearly half of people living with HIV (PWH) are diagnosed with at least one dermatologic condition despite advances in antiretroviral therapy (ART), according to a longitudinal cohort study published through the DC Cohort. Accor
- Dr. Michelle Henry Highlights Noninvasive Periorbital Rejuvenationhttps://practicaldermatology.com/news/dr-michelle-henry-highlights-noninvasive-periorbital-rejuvenation/2483904/Understanding facial aging patterns specific to richly pigmented skin and adjusting treatment approaches accordingly, especially as patient preferences shift away from traditional lower eyelid filler, is key in managing periorbital aging in patients with skin of color, Michelle Henry, MD, FAAD, s
- Study: Vagus Nerve Stimulation Improves ETR Symptomshttps://practicaldermatology.com/news/study-vagus-nerve-stimulation-improves-etr-symptoms/2483900/Results from a recent study suggest transcutaneous auricular vagus nerve stimulation (taVNS) could be a viable therapeutic option for patients with erythematotelangiectatic rosacea (ETR). Researchers for the randomized, double-
- Dr. Karan Lal Shares 'Recipe' for Prescribing GLP-1shttps://practicaldermatology.com/news/dr-karan-lal-shares-recipe-for-prescribing-glp-1s/2483869/The increasingly understood relevance of weight-loss drugs to inflammatory skin conditions was a hot topic at the Skin of Color Update in New York, New York, and Karan Lal, DO, FAAD, shared his “recipe” for addressing it with patients. Dr. Lal first checks for prior diagnoses of diabetes m
- Latino Melanoma Patients Face Barriers to Early Diagnosis and Treatmenthttps://practicaldermatology.com/news/latino-melanoma-patients-face-barriers-to-early-diagnosis-and-treatment/2483846/A new qualitative study published in JAMA Dermatology explored persistent disparities Latino patients face in timely melanoma diagnosis and treatment, despite advances in therapy that have improved survival among non-Hispani
- IFPA Highlights Patient Voices in Global Health Policy at UN Panelhttps://practicaldermatology.com/news/ifpa-highlights-patient-voices-in-global-health-policy/2483540/The International Federation of Psoriatic Disease Associations (IFPA) issued a call to global policymakers to recognize psoriatic disease as a serious noncommunicable disease (NCD) with system-wide implications at the 80th UN General Assembly in New York.